Søgeresultater - Enrico Capochiani
- Showing 1 - 2 results of 2
-
1
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a pros... af Mathias Rummel, T.M. Kim, Franco Aversa, Wolfram Brugger, Enrico Capochiani, Caterina Plenteda, Francesca Re, Peter C. Trask, Stuart Osborne, Rodney B.W. Smith, Andrew Grigg
Udgivet 2016Artigo -
2
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol af Enrico Capochiani, Bruno Frediani, Giorgio Iervasi, Aldo Paolicchi, Spartaco Sani, P Roncucci, Annarosa Cuccaro, Federico Franchi, Federico Simonetti, Davide Carrara, Ilaria Bertaggia, Daniela Nasso, Rossella Riccioni, Sabino Scolletta, Serafina Valente, Edoardo Conticini, Alessandro Gozzetti, Monica Bocchia
Udgivet 2020Artigo
Søgeredskaber:
Relaterede emner
Internal medicine
Medicine
Acute respiratory distress
Adverse effect
Alternative medicine
Bone marrow
CHOP
Chemotherapy
Coronavirus
Coronavirus disease 2019 (COVID-19)
Cyclophosphamide
Disease
Follicular lymphoma
Gastroenterology
Immunology
Infectious disease (medical specialty)
Intensive care medicine
Lung
Lymphoma
Myelofibrosis
Oncology
Pathology
Prednisone
Protocol (science)
Rituximab
Ruxolitinib
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Surgery
Vincristine